Results 21 to 30 of about 1,970 (212)

Arginase in glomerulonephritis [PDF]

open access: yesKidney International, 2002
l-Arginine is converted to nitric oxide and citrulline by the enzyme nitric oxide synthase (NOS). Its in vivo inhibition has led to the revelation of a multitude of diverse, often conflicting functions in the inflammatory melee. l-Arginine is also converted to ornithine and urea by the enzyme arginase as a part of the hepatic urea cycle.
openaire   +2 more sources

Evaluation of optimal conditions for arginase activity in streptozotocin induced diabetic rats

open access: yesVeterinární Medicína, 2005
The assay conditions needed to achieve maximal activity of liver and kidney arginase in diabetic and non-diabetic rats were investigated and compared.
M. Erisir, E. Ercel, S. Yilmaz, S. Ozan
doaj   +1 more source

Role of Arginase 2 as a potential pharmacological target for the creation of new drugs to correct cardiovascular diseases [PDF]

open access: yesResearch Results in Pharmacology, 2020
Introduction: The review provides relevant information about arginase 2, the role of this enzyme in the formation of endothelial dysfunction and, as a consequence, the development of cardiovascular diseases.
Sergey A. Demchenko   +2 more
doaj   +3 more sources

Arginase and pulmonary diseases [PDF]

open access: yesNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
Recent studies have indicated that arginase, which converts L-arginine into L-ornithine and urea, may play an important role in the pathogenesis of various pulmonary disorders. In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of ...
Maarsingh, Harm   +2 more
openaire   +3 more sources

Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia

open access: yesMolecular Genetics and Metabolism Reports, 2021
Arginase deficiency is a rare inborn error of metabolism that interrupts the final step of the urea cycle. Untreated individuals often present with episodic hyperammonemia, developmental delay, cognitive impairment, and spasticity in early childhood. The
Yue Huang   +14 more
doaj   +1 more source

Hypoxic Proliferation of Osteosarcoma Cells Depends on Arginase II

open access: yesCellular Physiology and Biochemistry, 2016
Background/Aims: Despite significant advancements in the diagnosis and treatment of osteosarcoma, the overall survival has remained relatively unchanged for over two decades.
Bhuvana A. Setty   +5 more
doaj   +1 more source

Strategies to rescue the consequences of inducible arginase-1 deficiency in mice. [PDF]

open access: yesPLoS ONE, 2015
Arginase-1 catalyzes the conversion of arginine to ornithine and urea, which is the final step of the urea cycle used to remove excess ammonia from the body.
Laurel L Ballantyne   +9 more
doaj   +1 more source

Role of arginase in vessel wall remodeling

open access: yesFrontiers in Immunology, 2013
Arginase metabolizes the semi-essential amino acid L-arginine to L-ornithine and urea. There are two distinct isoforms of arginase, arginase I and II, which are encoded by separate genes and display differences in tissue distribution, subcellular ...
William eDurante
doaj   +1 more source

Disturbance of Arginase Activity and Nitric Oxide Levels in Iraqi Type 2 Diabetes Mellitus

open access: yesمجلة بغداد للعلوم, 2018
This study is an attempt to find whether arginine metabolism dysregulation by arginase activity is related to hyperglycemia, followed by changes in nitric oxide (NO) generation in type 2 diabetic patients. This study includes 42 control subjects (Group I)
Baghdad Science Journal
doaj   +1 more source

Macrophage Membrane‐Camouflaged Nanozyme Microneedles Restore Immunovascular Homeostasis Through SPP1‐ApoE Signaling in Diabetic Wounds

open access: yesAdvanced Healthcare Materials, EarlyView.
Macrophage membrane‐coated Cu/Zn‐MOF nanozyme microneedles (MNs) reprogram the diabetic wound microenvironment through localized, minimally invasive delivery. By suppressing M1‐like macrophage activation while promoting extracellular matrix deposition and angiogenesis, this biomimetic platform accelerates diabetic wound repair.
Qipeng Wu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy